Spots Global Cancer Trial Database for glioblastoma multiforme of brain
Every month we try and update this database with for glioblastoma multiforme of brain cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas | NCT04869449 | Glioblastoma Glioblastoma Mu... Glioblastoma Mu... Glioblastoma Mu... | Ketoconazole | 18 Years - | Milton S. Hershey Medical Center | |
| Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) | NCT05685004 | Glioblastoma Mu... | TVI-Brain-1 Standard of Car... Radiotherapy Temozolomide | 18 Years - 80 Years | TVAX Biomedical | |
| Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme | NCT00003456 | Glioblastoma Mu... | Antineoplaston ... | 18 Years - 99 Years | Burzynski Research Institute | |
| Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) | NCT05685004 | Glioblastoma Mu... | TVI-Brain-1 Standard of Car... Radiotherapy Temozolomide | 18 Years - 80 Years | TVAX Biomedical | |
| Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery | NCT04968366 | Glioblastoma Mu... | Autologous dend... Temozolomide ad... | 18 Years - 75 Years | Beijing Tiantan Hospital | |
| Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma | NCT03633552 | Glioblastoma Mu... Anaplastic Astr... | Temozolomide | 18 Years - 70 Years | Mashhad University of Medical Sciences | |
| The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors | NCT05116137 | Glioblastoma Mu... Brain Cancer | Circuit-based r... | 18 Years - | Nova Scotia Health Authority | |
| Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas | NCT04869449 | Glioblastoma Glioblastoma Mu... Glioblastoma Mu... Glioblastoma Mu... | Ketoconazole | 18 Years - | Milton S. Hershey Medical Center | |
| Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma | NCT05076513 | Glioblastoma Glioblastoma Mu... Glioma GBM Glioma, Maligna... Glioblastoma Mu... | Niraparib Radiation thera... | 18 Years - | St. Joseph's Hospital and Medical Center, Phoenix | |
| Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot Study | NCT02302235 | Glioblastoma Mu... | Ketogenic Diet Standardized Di... | 18 Years - 65 Years | Mid-Atlantic Epilepsy and Sleep Center, LLC | |
| CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma | NCT05627323 | Glioblastoma Mu... | CHM-1101 CAR-T ... | 18 Years - | Chimeric Therapeutics | |
| MRSI to Predict Response to RT/TMZ ± Belinostat in GBM | NCT02137759 | Glioblastoma Mu... | Standard Radiat... Standard Temozo... Belinostat | 18 Years - | Emory University | |
| Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients | NCT02649582 | Glioblastoma Mu... | Dendritic cell ... | 18 Years - | University Hospital, Antwerp | |
| Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme | NCT03170141 | Glioblastoma Mu... Glioblastoma Mu... | Antigen-specifi... | 1 Year - 80 Years | Shenzhen Geno-Immune Medical Institute | |
| Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1) | NCT06193174 | Recurrent Malig... Glioblastoma Mu... Gliosarcoma of ... Anaplastic Astr... | C134 Re-Adminis... | 18 Years - | University of Alabama at Birmingham | |
| Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma | NCT06186440 | Glioblastoma Mu... | Cisplatin Plus ... Temozolomide | 18 Years - 75 Years | Zhongnan Hospital | |
| Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM) | NCT04222309 | Glioma Glioma, Maligna... Glioblastoma Glioblastoma Mu... Glioblastoma Mu... GBM Brain Cancer | Laparoscopicall... | 18 Years - | Northwell Health | |
| A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma | NCT05095441 | Solid Tumor Glioblastoma Glioblastoma Mu... Glioblastoma Mu... | C5252 | 18 Years - | ImmVira Pharma Co. Ltd | |
| Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme | NCT03047473 | Glioblastoma Mu... | avelumab | 18 Years - | Clinique Neuro-Outaouais | |
| Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma | NCT06186440 | Glioblastoma Mu... | Cisplatin Plus ... Temozolomide | 18 Years - 75 Years | Zhongnan Hospital | |
| Trial of C134 in Patients With Recurrent GBM | NCT03657576 | Glioblastoma Mu... Anaplastic Astr... Gliosarcoma of ... | C134 | 18 Years - | University of Alabama at Birmingham | |
| Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM) | NCT05979064 | Glioma Glioma, Maligna... Glioblastoma Glioblastoma Mu... Glioblastoma Mu... GBM Brain Cancer High Grade Glio... | Laparoscopicall... | 18 Years - | Northwell Health | |
| The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302) | NCT06283927 | Glioblastoma Glioblastoma Mu... Glioblastoma, I... Glioblastoma Mu... Glioblastoma Mu... Recurrent Gliob... Astrocytoma, Ma... Astrocytoma of ... | Re-resection Temozolomide Lomustine Re-irradiation Experimental th... Best supportive... | 18 Years - 90 Years | Erasmus Medical Center | |
| Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial | NCT04825275 | Glioblastoma Glioblastoma Mu... Glioblastoma Mu... Glioblastoma Mu... | Posaconazole Pi... | 18 Years - | Milton S. Hershey Medical Center | |
| CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma | NCT05627323 | Glioblastoma Mu... | CHM-1101 CAR-T ... | 18 Years - | Chimeric Therapeutics | |
| Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) | NCT05685004 | Glioblastoma Mu... | TVI-Brain-1 Standard of Car... Radiotherapy Temozolomide | 18 Years - 80 Years | TVAX Biomedical | |
| MRSI to Predict Response to RT/TMZ ± Belinostat in GBM | NCT02137759 | Glioblastoma Mu... | Standard Radiat... Standard Temozo... Belinostat | 18 Years - | Emory University | |
| Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac® | NCT05363826 | Glioblastoma Mu... Glioma, Sarcoma... | photochemothera... | 18 Years - | Photolitec LLC | |
| Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) | NCT05685004 | Glioblastoma Mu... | TVI-Brain-1 Standard of Car... Radiotherapy Temozolomide | 18 Years - 80 Years | TVAX Biomedical | |
| Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot Study | NCT02302235 | Glioblastoma Mu... | Ketogenic Diet Standardized Di... | 18 Years - 65 Years | Mid-Atlantic Epilepsy and Sleep Center, LLC | |
| Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial | NCT04825275 | Glioblastoma Glioblastoma Mu... Glioblastoma Mu... Glioblastoma Mu... | Posaconazole Pi... | 18 Years - | Milton S. Hershey Medical Center | |
| The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients. | NCT03861299 | Glioblastoma Glioblastoma Mu... Glioblastoma Mu... Astrocytoma, Gr... Brain Tumor Brain Cancer Brain Neoplasms | Awake craniotom... Craniotomy unde... | 18 Years - 90 Years | Erasmus Medical Center | |
| Multi Peptide Vaccination With XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma | NCT04842513 | Glioblastoma Mu... | Multipeptide pl... | 18 Years - | University Hospital Tuebingen | |
| The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202) | NCT06146725 | Glioblastoma Glioblastoma, I... Glioblastoma Mu... Glioblastoma Mu... Glioblastoma Mu... | Tumor resection Tumor biopsy | 18 Years - 90 Years | Erasmus Medical Center | |
| [18F]FPIA PET-CT in Glioblastoma Multiforme (GBM) | NCT05801159 | Glioblastoma Mu... | Positron Emissi... | 18 Years - | Imperial College London | |
| Effect of Deep TMS on the Permeability of the BBB in Patients With Glioblastoma Multiforme: a Pilot Study | NCT02474966 | Glioblastoma Mu... | Deep Transcrani... | 18 Years - 65 Years | University of Roma La Sapienza |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
